PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Global Regulatory Affairs, Sanofi R&D, Chilly Mazarin, France.\', \'Global Regulatory Affairs, Sanofi R&D, Chilly Mazarin, France. Electronic address: thomas.kuhler@sanofi.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0149-2918(20)30525-710.1016/j.clinthera.2020.11.015
?:doi
?:hasPublicationType
?:journal
  • Clinical therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 33353762
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.151
?:rankingScore_hIndex
  • 120
?:title
  • Regulatory Agilities in the Time of COVID-19: Overview, Trends, and Opportunities.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33353762>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33353762>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all